loadpatents
name:-0.032781839370728
name:-0.024279117584229
name:-0.013656139373779
WU; Chengde Patent Filings

WU; Chengde

Patent Applications and Registrations

Patent applications and USPTO patent grants for WU; Chengde.The latest application filed is for "sglts/dpp4 inhibitor and application thereof".

Company Profile
14.41.49
  • WU; Chengde - Shanghai CN
  • Wu; Chengde - Jiangsu CN
  • Wu; Chengde - Wuhan CN
  • Wu; Chengde - Pearland TX
  • Wu; Chengde - Houston TX
  • Wu, Chengde - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Sglts/dpp4 Inhibitor And Application Thereof
App 20220259247 - MAO; Qinghua ;   et al.
2022-08-18
Sglt2/dpp4 Inhibitor And Application Thereof
App 20220242898 - MAO; Qinghua ;   et al.
2022-08-04
Crystal Form of Quinazolinone Compound and Preparation Method Therefor
App 20220213060 - Huang; Jingjie ;   et al.
2022-07-07
Macrocyclic Derivatives Acting As Xia Factor Inhibitor
App 20220204508 - Cai; Yaxian ;   et al.
2022-06-30
Brd4 Inhibitor Compound In Solid Form And Preparation Method Therefor And Use Thereof
App 20220185820 - SHEN; Chunli ;   et al.
2022-06-16
Compounds Having Both Effects Of Bet Bromodomain Protein Inhibition And Pd-l1 Gene Regulation
App 20220177490 - SHEN; Chunli ;   et al.
2022-06-09
Glucoside Derivative That Acts As Sglt1 Inhibitor And Application Thereof
App 20220153772 - LI; Yi ;   et al.
2022-05-19
Diarylthiohydantoin compound as androgen receptor antagonist
Grant 11,332,465 - Shen , et al. May 17, 2
2022-05-17
Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof
App 20220135588 - YU; Tao ;   et al.
2022-05-05
Thienodiazepine derivatives and application thereof
Grant 11,312,726 - Shen , et al. April 26, 2
2022-04-26
Pyrazolopyrimidine Derivative And Use Thereof As Pi3k Inhibitor
App 20220112217 - WU; Chengde ;   et al.
2022-04-14
Crystal form as ASK1 inhibitor and preparation method and application thereof
App 20210269441 - ZHANG; Shengbin ;   et al.
2021-09-02
Pyridine derivative as ASK1 inhibitor and preparation method and use thereof
Grant 11,040,968 - Wu , et al. June 22, 2
2021-06-22
Coumarin-like cyclic compound as MEK inhibitor and use thereof
Grant 11,021,486 - Mao , et al. June 1, 2
2021-06-01
Thienodiazepine Derivatives And Application Thereof
App 20210017190 - SHEN; Chunli ;   et al.
2021-01-21
SGLTS inhibitor and application thereof
Grant 10,822,365 - Wu , et al. November 3, 2
2020-11-03
Sglts Inhibitor And Application Thereof
App 20200331950 - WU; CHENGDE ;   et al.
2020-10-22
Quinazolinone Compound and Application Thereof
App 20200317660 - WU; Chengde ;   et al.
2020-10-08
ASK1 inhibitor and preparation method and use thereof
Grant 10,787,435 - Wu , et al. September 29, 2
2020-09-29
Diarylthiohydantoin Compound As Androgen Receptor Antagonist
App 20200277290 - SHEN; Chunli ;   et al.
2020-09-03
BTK inhibitor
Grant 10,662,174 - Wang , et al.
2020-05-26
Coumarin-like Cyclic Compound As Mek Inhibitor And Use Thereof
App 20200148695 - MAO; Qinghua ;   et al.
2020-05-14
Pyridine Derivative As Ask1 Inhibitor And Preparation Method And Use Thereof
App 20200031823 - WU; Chengde ;   et al.
2020-01-30
Piperidine compounds as PCSK9 inhibitors
Grant 10,513,514 - Wu , et al. Dec
2019-12-24
Ask1 Inhibitor And Preparation Method And Use Thereof
App 20190375728 - Wu; Chengde ;   et al.
2019-12-12
Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor
Grant 10,479,789 - Yu , et al. Nov
2019-11-19
Substituted pyrrolidines as mGluR5 antagonists
Grant 10,328,054 - Chen , et al.
2019-06-25
Compounds as rearranged during transfection (RET) inhibitors
Grant 10,294,236 - Cheung , et al.
2019-05-21
Pyrido[1,2-a]pyrimidone Analog, Crystal Form Thereof, Intermediate Thereof And Preparation Method Therefor
App 20180319799 - Yu; Tao ;   et al.
2018-11-08
Pyrrolidine Derivatives
App 20180318254 - Chen; Li ;   et al.
2018-11-08
Piperidine Compounds As Pcsk9 Inhibitors
App 20180305346 - Wu; Chengde ;   et al.
2018-10-25
Novel Compounds As Rearranged During Transfection (ret) Inhibitors
App 20180099976 - Cheung; Mui ;   et al.
2018-04-12
Compounds as rearranged during transfection (RET) inhibitors
Grant 9,879,021 - Cheung , et al. January 30, 2
2018-01-30
Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitor
Grant 9,868,737 - Guan , et al. January 16, 2
2018-01-16
Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor
Grant 9,856,256 - Wu , et al. January 2, 2
2018-01-02
DGAT1 inhibitor and preparation method and use thereof
Grant 9,809,604 - Wu , et al. November 7, 2
2017-11-07
Btk Inhibitor
App 20170313683 - Wang; Xuehai ;   et al.
2017-11-02
Novel Compounds As Rearranged During Transfection (ret) Inhibitors
App 20170298074 - CHEUNG; Mui ;   et al.
2017-10-19
Pyridino[1,2-a]pyrimidone Analogue Used As P13k Inhibitor
App 20170137420 - WU; Chengde ;   et al.
2017-05-18
Pyridino[1,2-a]pyrimidone Analogue Used As Mtor/p13k Inhibitor
App 20170129888 - GUAN; Huiping ;   et al.
2017-05-11
DGAT1 Inhibitor and Preparation Method and Use Thereof
App 20160272651 - Wu; Chengde ;   et al.
2016-09-22
Tricyclic Sulfonamide Derivatives
App 20150183802 - CHEN; Shuhui ;   et al.
2015-07-02
Compounds as rearranged during transfection (RET) inhibitors
Grant 9,035,063 - Eidam , et al. May 19, 2
2015-05-19
Compounds As Rearranged During Transfection (ret) Inhibitors
App 20150099762 - EIDAM; Hilary Schenck ;   et al.
2015-04-09
Compounds as rearranged during transfection (RET) inhibitors
Grant 8,937,071 - Eidam , et al. January 20, 2
2015-01-20
Novel Compounds As Rearranged During Transfection (ret) Inhibitors
App 20140275111 - EIDAM; Hilary Schenck ;   et al.
2014-09-18
Bis-pyridylpyridones As Melanin-concentrating Hormone Receptor Antagonists
App 20120083489 - Christensen IV; Siegfried Benjamin ;   et al.
2012-04-05
Bis-pyridylpyridones As Melanin-concentrating Hormone Receptor 1 Antagonists
App 20120077794 - Christensen, IV; Siegfried Benjamin ;   et al.
2012-03-29
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
Grant 7,812,038 - Biediger , et al. October 12, 2
2010-10-12
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
Grant 7,579,340 - Biediger , et al. August 25, 2
2009-08-25
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
Grant 7,320,989 - Anderson , et al. January 22, 2
2008-01-22
Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
Grant 7,319,111 - Gao , et al. January 15, 2
2008-01-15
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
App 20080004312 - Anderson; Eric ;   et al.
2008-01-03
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
App 20070293503 - Biediger; Ronald ;   et al.
2007-12-20
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
Grant 7,288,538 - Wu , et al. October 30, 2
2007-10-30
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
Grant 7,265,122 - Wu , et al. September 4, 2
2007-09-04
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
App 20060276476 - Biediger; Ronald J. ;   et al.
2006-12-07
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
Grant 6,972,296 - Biediger , et al. December 6, 2
2005-12-06
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
App 20050054850 - Wu, Chengde ;   et al.
2005-03-10
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
App 20050049286 - Wu, Chengde ;   et al.
2005-03-03
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
App 20040186102 - Wu, Chengde ;   et al.
2004-09-23
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
App 20040180892 - Wu, Chengde ;   et al.
2004-09-16
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
Grant 6,723,711 - Biediger , et al. April 20, 2
2004-04-20
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
App 20040063955 - Biediger, Ronald J. ;   et al.
2004-04-01
Sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 6,686,382 - Wu , et al. February 3, 2
2004-02-03
Sulfonamides for treatment of endothelin-mediated disorders
Grant 6,683,103 - Wu , et al. January 27, 2
2004-01-27
Sulfonamides and derivatives thereof that modulate the activity of endothelin
App 20030208084 - Wu, Chengde ;   et al.
2003-11-06
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
App 20030199692 - Biediger, Ronald J. ;   et al.
2003-10-23
Sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 6,632,829 - Wu , et al. October 14, 2
2003-10-14
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
Grant 6,541,498 - Chan , et al. April 1, 2
2003-04-01
Sulfonamides for treatment of endothelin-mediated disorders
Grant 6,432,994 - Wu , et al. August 13, 2
2002-08-13
N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelin
Grant 6,420,567 - Wu , et al. July 16, 2
2002-07-16
Sulfonamides for treatment of endothelin-mediated disorders
App 20020091270 - Wu, Chengde ;   et al.
2002-07-11
Sulfonamides and derivatives thereof that modulate the activity of endothelin
App 20020091272 - Wu, Chengde ;   et al.
2002-07-11
Sulfonamides and derivatives thereof that modulate the activity of endothelin
App 20010056183 - Wu, Chengde ;   et al.
2001-12-27
N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 6,331,637 - Chan , et al. December 18, 2
2001-12-18
Formulation of sulfonamides for treatment of endothelin-mediated disorders
App 20010039289 - Blok, Natalie ;   et al.
2001-11-08
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
App 20010036958 - Chan, Ming Fai ;   et al.
2001-11-01
Thienyl-, Furyl-, Pyrrolyl- And Biphenylsulfonamides And Derivatives Thereof That Modulate The Activity Of Endothelin
App 20010021714 - CHAN, MING FAI ;   et al.
2001-09-13
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
App 20010014694 - Chan, Ming Fai ;   et al.
2001-08-16
Compounds that inhibit the binding of integrins to their receptors
Grant 6,262,084 - Biediger , et al. July 17, 2
2001-07-17
Formulation of sulfonamides for treatment of endothelin-mediated disorders
Grant 6,248,767 - Blok , et al. June 19, 2
2001-06-19
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
Grant 6,030,991 - Chan , et al. February 29, 2
2000-02-29
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
Grant 5,977,117 - Chan , et al. November 2, 1
1999-11-02
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,962,490 - Chan , et al. October 5, 1
1999-10-05
Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,594,021 - Chan , et al. January 14, 1
1997-01-14
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,591,761 - Chan , et al. * January 7, 1
1997-01-07
Sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,571,821 - Chan , et al. November 5, 1
1996-11-05
N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,464,853 - Chan , et al. November 7, 1
1995-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed